172 related articles for article (PubMed ID: 16785804)
21. Articular
Ferraz-Amaro I; Sheikh A; Polack B; Giles JT; Bathon JM
J Rheumatol; 2022 Dec; 49(12):1315-1319. PubMed ID: 35970536
[TBL] [Abstract][Full Text] [Related]
22. The role of (18) F-fluorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with takayasu arteritis.
Lee KH; Cho A; Choi YJ; Lee SW; Ha YJ; Jung SJ; Park MC; Lee JD; Lee SK; Park YB
Arthritis Rheum; 2012 Mar; 64(3):866-75. PubMed ID: 21989701
[TBL] [Abstract][Full Text] [Related]
23. Predictive factors associated with the progression of large-joint destruction in patients with rheumatoid arthritis after biologic therapy: A post-hoc analysis using FDG-PET/CT and the ARASHI (assessment of rheumatoid arthritis by scoring of large-joint destruction and healing in radiographic imaging) scoring method.
Suto T; Yonemoto Y; Okamura K; Okura C; Kaneko T; Kobayashi T; Tachibana M; Tsushima Y; Takagishi K
Mod Rheumatol; 2017 Sep; 27(5):820-827. PubMed ID: 27919199
[TBL] [Abstract][Full Text] [Related]
24. FDG PET for rheumatoid arthritis: basic considerations and whole-body PET/CT.
Kubota K; Ito K; Morooka M; Minamimoto R; Miyata Y; Yamashita H; Takahashi Y; Mimori A
Ann N Y Acad Sci; 2011 Jun; 1228():29-38. PubMed ID: 21718320
[TBL] [Abstract][Full Text] [Related]
25. Joint accumulations of FDG in whole body PET scans.
von Schulthess GK; Meier N; Stumpe KD
Nuklearmedizin; 2001 Dec; 40(6):193-7. PubMed ID: 11797507
[TBL] [Abstract][Full Text] [Related]
26. Potential of (18)F-FDG-PET as a valuable adjunct to clinical and response assessment in rheumatoid arthritis and seronegative spondyloarthropathies.
Vijayant V; Sarma M; Aurangabadkar H; Bichile L; Basu S
World J Radiol; 2012 Dec; 4(12):462-8. PubMed ID: 23320137
[TBL] [Abstract][Full Text] [Related]
27. Effect of total knee arthroplasty on other joints in patients with rheumatoid arthritis evaluated by 18-FDG-PET.
Yonemoto Y; Okamura K; Kaneko T; Okura C; Kobayashi T; Suto T; Tsushima Y; Takagishi K
Int J Rheum Dis; 2017 Jun; 20(6):702-707. PubMed ID: 26991010
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory cytokines and hypoxia contribute to 18F-FDG uptake by cells involved in pannus formation in rheumatoid arthritis.
Matsui T; Nakata N; Nagai S; Nakatani A; Takahashi M; Momose T; Ohtomo K; Koyasu S
J Nucl Med; 2009 Jun; 50(6):920-6. PubMed ID: 19443596
[TBL] [Abstract][Full Text] [Related]
29. Myocardial Inflammation, Measured Using 18-Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography, Is Associated With Disease Activity in Rheumatoid Arthritis.
Amigues I; Tugcu A; Russo C; Giles JT; Morgenstein R; Zartoshti A; Schulze C; Flores R; Bokhari S; Bathon JM
Arthritis Rheumatol; 2019 Apr; 71(4):496-506. PubMed ID: 30407745
[TBL] [Abstract][Full Text] [Related]
30. Arterial Inflammation Detected With
Geraldino-Pardilla L; Zartoshti A; Bag Ozbek A; Giles JT; Weinberg R; Kinkhabwala M; Bokhari S; Bathon JM
Arthritis Rheumatol; 2018 Jan; 70(1):30-39. PubMed ID: 28992382
[TBL] [Abstract][Full Text] [Related]
31. F-18 FDG uptake patterns and disease activity of collagen vascular diseases-associated arthritis.
Okabe T; Shibata H; Shizukuishi K; Yoneyama T; Inoue T; Tateishi U
Clin Nucl Med; 2011 May; 36(5):350-4. PubMed ID: 21467850
[TBL] [Abstract][Full Text] [Related]
32. (18)F-FDG-PET assessment of early treatment response of articular and extra-articular foci in newly diagnosed rheumatoid arthritis.
Sarma M; Vijayant V; Basu S
Hell J Nucl Med; 2012; 15(1):70-1. PubMed ID: 22413120
[No Abstract] [Full Text] [Related]
33. Diagnostic value of 18F-fluorodeoxyglucose uptake parameters to differentiate rheumatoid arthritis from other types of arthritis.
Bhattarai A; Nakajima T; Sapkota S; Arisaka Y; Tokue A; Yonemoto Y; Tsushima Y
Medicine (Baltimore); 2017 Jun; 96(25):e7130. PubMed ID: 28640086
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT.
Okamura K; Yonemoto Y; Okura C; Higuchi T; Tsushima Y; Takagishi K
BMC Musculoskelet Disord; 2014 Nov; 15():393. PubMed ID: 25417119
[TBL] [Abstract][Full Text] [Related]
35. Quantitative tracking of inflammatory activity at the peak and trough plasma levels of tofacitinib, a Janus kinase inhibitor, via in vivo
Raychaudhuri S; Abria C; Harmany ZT; Smith CM; Kundu-Raychaudhuri S; Raychaudhuri SP; Chaudhari AJ
Int J Rheum Dis; 2019 Dec; 22(12):2165-2169. PubMed ID: 31659868
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of handy rheumatoid activity score with 38 joints (HRAS38) in rheumatoid arthritis patients receiving infliximab.
Kameda H; Sekiguchi N; Nagasawa H; Amano K; Takei H; Suzuki K; Nishi E; Ogawa H; Takeuchi T
Mod Rheumatol; 2006; 16(6):381-8. PubMed ID: 17165001
[TBL] [Abstract][Full Text] [Related]
37. Axillary lymph-node metabolic activity assessment on
Dam TT; Okamura K; Nakajima T; Yonemoto Y; Suto T; Arisaka Y; Tomonaga H; Tachibana M; Tajika T; Vu LD; Chikuda H; Tsushima Y
Scand J Rheumatol; 2020 Mar; 49(2):96-104. PubMed ID: 31578102
[No Abstract] [Full Text] [Related]
38. Axillary lymph node visualization on F-18 FDG PET body scans in patients with rheumatoid arthritis.
Seldin DW; Habib I; Soudry G
Clin Nucl Med; 2007 Jul; 32(7):524-6. PubMed ID: 17581335
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT.
Ben-Haim S; Kupzov E; Tamir A; Israel O
J Nucl Med; 2004 Nov; 45(11):1816-21. PubMed ID: 15534049
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic effects of acupuncture in patients with rheumatoid arthritis: a prospective study using (18)F-FDG-PET.
Sato M; Inubushi M; Shiga T; Hirata K; Okamoto S; Kamibayashi T; Tanimura K; Tamaki N
Ann Nucl Med; 2009 May; 23(3):311-6. PubMed ID: 19337783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
